Biomarker testing patterns and use of targeted therapy in Medicare Fee-for-Service (FFS) beneficiaries newly diagnosed with metastatic non-small cell lung cancer (mNSCLC).

被引：0
|
作者：
Patel, Anik
Jamotte, Aurelien
Matsuda, Tara
Das, Partha Manas
Elkhouly, Ehab
Xi, Ann
Jones, Barton
Murunga, Anne
Petrilla, Allison
Markward, Nathan
Stevinson, Kendall Lee
机构：
[1] Amgen Inc, Global Hlth Econ, Thousand Oaks, CA USA
[2] Amgen Europ, Econ Modeling CoE PACE, Rotkreuz, Switzerland
[3] Amgen Inc, US Med, Thousand Oaks, CA USA
[4] Amgen Inc, Global Med, Thousand Oaks, CA USA
[5] Avalere Hlth, Washington, DC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 29期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
278
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Therapy of Metastatic Non-small Cell Lung Cancer
    Reinmuth, N.
    Groeschel, A.
    Schumann, C.
    Sebastian, M.
    Wiewrodt, R.
    Reck, M.
    PNEUMOLOGIE, 2016, 70 (09): : 567 - 578
  • [32] Exposure patterns of immune checkpoint inhibitors among older Medicare beneficiaries with non-small cell lung cancer
    Bates, Benjamin
    Rua, Melanie
    Kania, Brooke
    Jiang, Alex
    Setoguchi, Soko
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 342 - 343
  • [33] Advancements in Non-Small Cell Lung Cancer Developments in predictive biomarker testing and targeted therapy in advanced stage non-small cell lung cancer and their application across European countries
    Jager, Vincent D. de
    Timens, Wim
    Bayle, Arnaud
    Botling, Johan
    Brcic, Luka
    Buettner, Reinhard
    Fernandes, Maria Gabriela O.
    Havel, Libor
    Hochmair, Maximilian J.
    Hofman, Paul
    Janssens, Annelies
    Johansson, Mikael
    van Kempen, Leon
    Kern, Izidor
    Lopez-Rios, Fernando
    Luchtenborg, Margreet
    Machado, Jose Carlos
    Mohorcic, Katja
    Paz-Ares, Luis
    Popat, Sanjay
    Ryska, Ales
    Taniere, Phillipe
    Wolf, Juergen
    Schuuring, Ed
    van der Wekkenz, Anthonie J.
    LANCET REGIONAL HEALTH-EUROPE, 2024, 38
  • [34] Communication About Prognosis and Illness Understanding Among Adults Receiving Targeted Therapy (TTx) for Metastatic Non-Small Cell Lung Cancer (mNSCLC)
    Petrillo, Laura
    Sommer, Robert
    Traeger, Lara
    Greer, Joseph
    Temel, Jennifer
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2020, 60 (01) : 208 - 209
  • [35] Clinical utility of comprehensive cell-free DNA (cfDNA) analysis to identify genomic biomarkers in newly diagnosed metastatic non-small cell lung cancer (mNSCLC)
    Leighl, Natasha
    Page, Ray D.
    Raymond, Victoria M.
    Daniel, Davey
    Divers, Stephen
    Reckamp, Karen L.
    Villalona-Calero, Miguel A.
    Dix, Daniel
    Jackson, Matthew
    Odegaard, Justin I.
    Papadimitrakopoulou, Vassiliki A.
    CANCER RESEARCH, 2019, 79 (13)
  • [36] Current perspectives on the use of miRNA as a biomarker for EGFR-targeted therapy for non-small cell lung cancer
    Florczuk, Mateusz
    Szpechcinski, Adam
    Chorostowska-Wynimko, Joanna
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2017, 71 : 1207 - 1218
  • [37] Associations between biomarker testing and characteristics of patients with metastatic non-small cell lung cancer (mNSCLC): An analysis of CancerLinQ Discovery (CLQD) data.
    Mileham, Kathryn Finch
    Garrett-Mayer, Elizabeth
    Kaltenbaugh, Melinda
    Kirkwood, Margaret Kelsey
    Schenkel, Caroline
    Bruinooge, Suanna Steeby
    Osarogiagbon, Raymond U.
    Jalal, Shadia Ibrahim
    Moore, Amy
    Roy, Upal Kunal Basu
    Freeman-Daily, Janet
    Virani, Shamsuddin
    Garon, Edward B.
    Silvestri, Gerard A.
    Rosenthal, Lauren
    Smith, Robert A.
    Johnson, Bruce E.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [38] Prevalence, Treatment Patterns, and Survival by Age in Patients Diagnosed with Metastatic Non-Small Cell Lung Cancer (mNSCLC) and Brain Metastases (BM) in the United States
    Danese, M.
    Korytowsky, B.
    Laurie, M.
    Scofield, A.
    Shafrin, J.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (03) : E40 - E40
  • [39] Time-to-treatment for metastatic non-small cell lung cancer in the era of biomarker testing
    Akanbi, Maxwell Oluwole
    Kenmoe, Jerry
    Adekolujo, Samuel O.
    Saleem, Muhammad
    Koduru, Ujwala
    Hrinczenko, Borys
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [40] Predictive biomarker testing rates in patients with metastatic non-small cell lung cancer in The Netherlands
    de Jager, V.
    Garcia, B. N. Cajiao
    Kuijpers, C. C.
    de Bock, G. H.
    Maas, W. J.
    Timens, W.
    van Kempen, L. C.
    van der Wekken, A. J.
    Schuuring, E.
    Willems, S. M.
    VIRCHOWS ARCHIV, 2024, 485 : S139 - S140
12345